Clinical Trial Update: Progression Suppression and Retinal Regression in VEGF-resistant AMD [NA]

View source ↗

Summary

This clinical trial update indicates ongoing recruitment for a study examining progression suppression and retinal regression in VEGF-resistant neovascular age-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Snippet

Sponsor: PharmaBio Corporation | Conditions: Neovascular Age-related Macular Degeneration (AMD) | NA | Status: RECRUITING